J.-Y. Douillard

A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)

Joaquı́n Mateo, Debyani Chakravarty, Rodrigo Dienstmann et al. · Annals of Oncology · 2018 · 728 citations · Full text

Final results from PRIME: randomized phase III study of panitumumab with FOLFOX4 for first-line treatment of metastatic colorectal cancer

J.-Y. Douillard, Salvatore Siena, J Cassidy et al. · Annals of Oncology · 2014 · 596 citations · Full text

European Society for Medical Oncology (ESMO) position paper on supportive and palliative care

Katja-Daniela Jordan, Matti Aapro, S. Kaasa et al. · Annals of Oncology · 2017 · 355 citations · Full text

ESMO recommendations on the standard methods to detect NTRK fusions in daily practice and clinical research

Caterina Marchiò, Maurizio Scaltriti, Marc Ladanyi et al. · Annals of Oncology · 2019 · 345 citations · Full text

Esmo Recommendations, Medicine, Ntrk Fusions +5

Pan-Asian adapted Clinical Practice Guidelines for the management of patients with metastatic non-small-cell lung cancer: a CSCO–ESMO initiative endorsed by JSMO, KSMO, MOS, SSO and TOS

Yi‐Long Wu, D. Planchard, Shun Lü et al. · Annals of Oncology · 2018 · 291 citations · Full text